• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CSL

CSL LIMITED - Discussion

0.38% ! $248.39
Market Cap $120.2B  !
Healthcare Biotechnology
Add to My Watchlist

CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus... CSL Limited is an Australia-based biotechnology company. The Company’s areas of focus include rare and serious diseases, influenza vaccines and iron deficiency and nephrology. The Company’s segments include CSL Behring, CSL Seqirus and CSL Vifor. The CSL Behring segment manufactures, markets and distributes plasma products, gene therapies and recombinants. The CSL Seqirus segment manufactures, markets and distributes predominantly influenza related products and provides pandemic services to governments. The CSL Vifor segment manufactures, markets and distributes products in the therapeutic areas of iron deficiency and nephrology. Its CSL Plasma operates plasma collection networks, with more than 325 plasma collection centers in the United States, Europe and China. The Company operates in Australia, the United States, Germany, the United Kingdom, Switzerland and China. Its products include Respreeza, Zemaira, HAEGARDA, KCENTRA, Hepatitis B, Evogam and others. More

Csl Limited

edit-2 Created with Sketch. New Thread
refresh Created with Sketch. REFRESH
Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX - By Stock CSL News: CSL New COVID-19 sa-mRNA Results From CSL And Arcturus Therapeutics Demonstrate Longer... Thread Hot News 2 1.3K 6 06/02/24
06/02/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.3K Likes Created with Sketch. 6
ASX - By Stock CSL Re: Csl112 Thread bagus 27 12K 0 05/02/24
05/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Csl112 Thread EMC22 27 12K 0 05/02/24
05/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Csl112 Thread Popp123 27 12K 2 05/02/24
05/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 2
ASX - By Stock CSL Re: Csl112 Thread EMC22 27 12K 4 05/02/24
05/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 4
ASX - By Stock CSL Re: Csl112 Thread Popp123 27 12K 3 05/02/24
05/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 3
ASX - By Stock CSL Re: Csl112 Thread bagus 27 12K 1 05/02/24
05/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 1
ASX - By Stock CSL Re: Csl112 Thread W534220 27 12K 3 04/02/24
04/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 3
ASX - By Stock CSL Re: Csl112 Thread W534220 27 12K 1 04/02/24
04/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 1
ASX - By Stock CSL Csl112 Thread Popp123 27 12K 3 03/02/24
03/02/24 ASX - By Stock Thread Comments Created with Sketch. 27 Views Created with Sketch. 12K Likes Created with Sketch. 3
ASX - By Stock CSL Takeda q3 IG revenue growth +18% Thread W534220 0 420 4 02/02/24
02/02/24 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 420 Likes Created with Sketch. 4
ASX - By Stock CSL Re: Csl112 Thread W534220 4 2.2K 3 02/02/24
02/02/24 ASX - By Stock Thread Comments Created with Sketch. 4 Views Created with Sketch. 2.2K Likes Created with Sketch. 3
ASX - By Stock CSL Re: $300 by calendar year end Thread Swage_17 13 6.8K 2 01/02/24
01/02/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 2
ASX - By Stock CSL Re: $300 by calendar year end Thread Popp123 13 6.8K 1 01/02/24
01/02/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 1
ASX - By Stock CSL Re: $300 by calendar year end Thread Silverchair 13 6.8K 6 01/02/24
01/02/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 6
ASX - By Stock CSL Re: $300 by calendar year end Thread TheAnalyst007 13 6.8K 2 01/02/24
01/02/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 2
ASX - By Stock CSL News: CSL UPDATE 1-UK regulator probes Vifor Pharma for anti-competitive conduct Thread Hot News 0 361 2 01/02/24
01/02/24 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 361 Likes Created with Sketch. 2
ASX - By Stock CSL Re: $300 by calendar year end Thread siren4 13 6.8K 0 31/01/24
31/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 0
ASX - By Stock CSL Re: $300 by calendar year end Thread Kunisagi 13 6.8K 2 31/01/24
31/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 2
ASX - By Stock CSL Re: $300 by calendar year end Thread wop 13 6.8K 5 31/01/24
31/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 5
ASX - By Stock CSL Re: $300 by calendar year end Thread W534220 13 6.8K 10 31/01/24
31/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 10
ASX - By Stock CSL Re: $300 by calendar year end Thread Cocky5 13 6.8K 3 31/01/24
31/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 3
ASX - By Stock CSL Re: $300 by calendar year end Thread TheAnalyst007 13 6.8K 7 31/01/24
31/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 7
ASX - By Stock CSL Re: $300 by calendar year end Thread Cocky5 13 6.8K 6 31/01/24
31/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 6
ASX - By Stock CSL Re: Csl112 Thread W534220 4 2.2K 3 30/01/24
30/01/24 ASX - By Stock Thread Comments Created with Sketch. 4 Views Created with Sketch. 2.2K Likes Created with Sketch. 3
ASX - By Stock CSL Re: Csl112 Thread alnby 4 2.2K 0 30/01/24
30/01/24 ASX - By Stock Thread Comments Created with Sketch. 4 Views Created with Sketch. 2.2K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Csl112 Thread W534220 4 2.2K 8 30/01/24
30/01/24 ASX - By Stock Thread Comments Created with Sketch. 4 Views Created with Sketch. 2.2K Likes Created with Sketch. 8
ASX - By Stock CSL Csl112 Thread W534220 4 2.2K 3 30/01/24
30/01/24 ASX - By Stock Thread Comments Created with Sketch. 4 Views Created with Sketch. 2.2K Likes Created with Sketch. 3
ASX - By Stock CSL Re: $300 by calendar year end Thread wop 13 6.8K 2 30/01/24
30/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 2
ASX - By Stock CSL Ann: Notice of Investor/Analyst Briefing 2024 Half Year Results Thread ASX News 0 676 1 30/01/24
30/01/24 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 676 Likes Created with Sketch. 1
ASX - By Stock CSL News: CSL Australia's oldest listed investment firm says lithium stocks turning attractive Thread Hot News 0 643 2 24/01/24
24/01/24 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 643 Likes Created with Sketch. 2
ASX - By Stock CSL Re: Csl112 aegis 2 trial results Thread Hoarding 2 1.8K 0 22/01/24
22/01/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.8K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Csl112 aegis 2 trial results Thread Hoarding 2 1.8K 0 22/01/24
22/01/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.8K Likes Created with Sketch. 0
ASX - By Stock CSL Csl112 aegis 2 trial results Thread W534220 2 1.8K 0 22/01/24
22/01/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.8K Likes Created with Sketch. 0
Charts CSL Re: CSL Chart Thread Somme 1.1K 713K 1 19/01/24
19/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 1
Charts CSL Re: CSL Chart Thread slick 1.1K 713K 2 17/01/24
17/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
Charts CSL Re: CSL Chart Thread BuffettWarren 1.1K 713K 1 16/01/24
16/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 1
Charts CSL Re: CSL Chart Thread slick 1.1K 713K 0 16/01/24
16/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 0
Charts CSL Re: CSL Chart Thread BuffettWarren 1.1K 713K 0 16/01/24
16/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 0
Charts CSL Re: CSL Chart Thread slick 1.1K 713K 3 16/01/24
16/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 3
ASX - By Stock CSL Re: Garadacimab and csl112 Thread Burgerbuns 13 7.7K 6 12/01/24
12/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 6
ASX - By Stock CSL Re: Garadacimab and csl112 Thread W534220 13 7.7K 3 11/01/24
11/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 3
ASX - By Stock CSL Re: Garadacimab and csl112 Thread W534220 13 7.7K 4 11/01/24
11/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 4
ASX - By Stock CSL Re: Garadacimab and csl112 Thread JoeGambler 13 7.7K 0 11/01/24
11/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Garadacimab and csl112 Thread W534220 13 7.7K 0 11/01/24
11/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Garadacimab and csl112 Thread JoeGambler 13 7.7K 0 11/01/24
11/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Garadacimab and csl112 Thread W534220 13 7.7K 6 11/01/24
11/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 6
ASX - By Stock CSL Re: Grifols Thread W534220 2 1.4K 0 11/01/24
11/01/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.4K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Grifols Thread JoeGambler 2 1.4K 1 10/01/24
10/01/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.4K Likes Created with Sketch. 1
ASX - By Stock CSL Re: Garadacimab and csl112 Thread JoeGambler 13 7.7K 1 10/01/24
10/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 1
ASX - By Stock CSL Re: Garadacimab and csl112 Thread Swage_17 13 7.7K 0 10/01/24
10/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Garadacimab and csl112 Thread JoeGambler 13 7.7K 2 10/01/24
10/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 2
ASX - By Stock CSL Grifols Thread PZ99 2 1.4K 11 10/01/24
10/01/24 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.4K Likes Created with Sketch. 11
ASX - By Stock CSL Ann: Notification of cessation of securities - CSL Thread ASX News 0 672 1 09/01/24
09/01/24 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 672 Likes Created with Sketch. 1
Charts CSL Re: CSL Chart Thread Chella 1.1K 713K 0 09/01/24
09/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 0
Charts CSL Re: CSL Chart Thread slick 1.1K 713K 6 06/01/24
06/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 6
ASX - By Stock CSL Re: Garadacimab and csl112 Thread redpencil 13 7.7K 2 02/01/24
02/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 2
ASX - By Stock CSL Re: Garadacimab and csl112 Thread Hoarding 13 7.7K 0 02/01/24
02/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Garadacimab and csl112 Thread StockholmRod 13 7.7K 0 02/01/24
02/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 0
ASX - By Stock CSL Garadacimab and csl112 Thread W534220 13 7.7K 1 02/01/24
02/01/24 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 7.7K Likes Created with Sketch. 1
Charts CSL Re: CSL Chart Thread W534220 1.1K 713K 1 02/01/24
02/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 1
ASX - By Stock CSL Ann: Appendix 3X Initial Director's Interest Notice Thread ASX News 0 668 1 02/01/24
02/01/24 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 668 Likes Created with Sketch. 1
Charts CSL Re: CSL Chart Thread Chella 1.1K 713K 0 01/01/24
01/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 0
Charts CSL Re: CSL Chart Thread Samyouel 1.1K 713K 2 01/01/24
01/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
Charts CSL Re: CSL Chart Thread W534220 1.1K 713K 2 01/01/24
01/01/24 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
Charts CSL Re: CSL Chart Thread Samyouel 1.1K 713K 3 31/12/23
31/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 3
Charts CSL Re: CSL Chart Thread Kevyg1609 1.1K 713K 3 31/12/23
31/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 3
Charts CSL Re: CSL Chart Thread Sunny6991 1.1K 713K 3 28/12/23
28/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 3
Charts CSL Re: CSL Chart Thread Chris60 1.1K 713K 0 22/12/23
22/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 0
ASX - By Stock CSL Re: Another vyvgart trial fail Thread W534220 2 1.5K 1 22/12/23
22/12/23 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.5K Likes Created with Sketch. 1
ASX - By Stock CSL Re: Another vyvgart trial fail Thread JoeGambler 2 1.5K 0 22/12/23
22/12/23 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.5K Likes Created with Sketch. 0
ASX - By Stock CSL Re: News: CSL CSL and Arcturus Therapeutics' Arct-154 Demonstrates Non-Inferiority To Original Strain Thread W534220 1 947 4 22/12/23
22/12/23 ASX - By Stock Thread Comments Created with Sketch. 1 Views Created with Sketch. 947 Likes Created with Sketch. 4
ASX - By Stock CSL Another vyvgart trial fail Thread W534220 2 1.5K 4 22/12/23
22/12/23 ASX - By Stock Thread Comments Created with Sketch. 2 Views Created with Sketch. 1.5K Likes Created with Sketch. 4
ASX - By Stock CSL News: CSL CSL and Arcturus Therapeutics' Arct-154 Demonstrates Non-Inferiority To Original Strain Thread Hot News 1 947 5 22/12/23
22/12/23 ASX - By Stock Thread Comments Created with Sketch. 1 Views Created with Sketch. 947 Likes Created with Sketch. 5
ASX - By Stock CSL News: CSL Csl And Arcturus Therapeutics' Arct-154 Demonstrates Non-Inferiority To Original Strain... Thread Hot News 0 282 0 22/12/23
22/12/23 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 282 Likes Created with Sketch. 0
Charts CSL Re: CSL Chart Thread thunderhead1 1.1K 713K 2 21/12/23
21/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
Charts CSL Re: CSL Chart Thread BuffettWarren 1.1K 713K 2 21/12/23
21/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
Charts CSL Re: CSL Chart Thread siren4 1.1K 713K 2 21/12/23
21/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
Charts CSL Re: CSL Chart Thread Jike 1.1K 713K 3 20/12/23
20/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 3
Charts CSL Re: CSL Chart Thread BuffettWarren 1.1K 713K 1 20/12/23
20/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 1
Charts CSL Re: CSL Chart Thread W534220 1.1K 713K 4 20/12/23
20/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 4
Charts CSL Re: CSL Chart Thread bagus 1.1K 713K 0 20/12/23
20/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 0
Charts CSL Re: CSL Chart Thread bagus 1.1K 713K 2 20/12/23
20/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
Charts CSL Re: CSL Chart Thread Sunny6991 1.1K 713K 0 20/12/23
20/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 0
ASX - By Stock CSL Article discussing the sa-mRNA advance Thread W534220 0 403 3 19/12/23
19/12/23 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 403 Likes Created with Sketch. 3
Charts CSL Re: CSL Chart Thread thunderhead1 1.1K 713K 2 19/12/23
19/12/23 Charts Thread Comments Created with Sketch. 1.1K Views Created with Sketch. 713K Likes Created with Sketch. 2
ASX - By Stock CSL Re: News: CSL CSL Ltd Says Garadacimab Received FDA And EMA Filing Acceptance Thread siren4 5 2.6K 2 19/12/23
19/12/23 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.6K Likes Created with Sketch. 2
ASX - By Stock CSL Re: News: CSL CSL Ltd Says Garadacimab Received FDA And EMA Filing Acceptance Thread smob 5 2.6K 7 17/12/23
17/12/23 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.6K Likes Created with Sketch. 7
ASX - By Stock CSL Re: News: CSL CSL Ltd Says Garadacimab Received FDA And EMA Filing Acceptance Thread W534220 5 2.6K 1 16/12/23
16/12/23 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.6K Likes Created with Sketch. 1
ASX - By Stock CSL Re: News: CSL CSL Ltd Says Garadacimab Received FDA And EMA Filing Acceptance Thread W534220 5 2.6K 0 16/12/23
16/12/23 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.6K Likes Created with Sketch. 0
ASX - By Stock CSL Re: News: CSL CSL Ltd Says Garadacimab Received FDA And EMA Filing Acceptance Thread W534220 5 2.6K 1 16/12/23
16/12/23 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.6K Likes Created with Sketch. 1
ASX - By Stock CSL News: CSL UPDATE 1-Uptake of new hemophilia gene therapies slow as field assesses options Thread Hot News 0 372 0 16/12/23
16/12/23 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 372 Likes Created with Sketch. 0
ASX - By Stock CSL News: CSL Uptake of new hemophilia gene therapies slow as field assesses options Thread Hot News 0 324 1 15/12/23
15/12/23 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 324 Likes Created with Sketch. 1
ASX - By Stock CSL News: CSL CSL Ltd Says Garadacimab Received FDA And EMA Filing Acceptance Thread Hot News 5 2.6K 4 15/12/23
15/12/23 ASX - By Stock Thread Comments Created with Sketch. 5 Views Created with Sketch. 2.6K Likes Created with Sketch. 4
ASX - By Stock CSL Ann: Securities Dealing Policy Thread ASX News 0 434 0 15/12/23
15/12/23 ASX - By Stock Thread Comments Created with Sketch. 0 Views Created with Sketch. 434 Likes Created with Sketch. 0
ASX - By Stock CSL Re: $300 by calendar year end Thread BigB87 13 6.8K 2 15/12/23
15/12/23 ASX - By Stock Thread Comments Created with Sketch. 13 Views Created with Sketch. 6.8K Likes Created with Sketch. 2
Charts CSL Re: Is Aegros a genuine Threat to CSL? Thread gadgetman 79 85K 6 14/12/23
14/12/23 Charts Thread Comments Created with Sketch. 79 Views Created with Sketch. 85K Likes Created with Sketch. 6
Charts CSL Re: Is Aegros a genuine Threat to CSL? Thread gadgetman 79 85K 1 14/12/23
14/12/23 Charts Thread Comments Created with Sketch. 79 Views Created with Sketch. 85K Likes Created with Sketch. 1
Charts CSL Re: Is Aegros a genuine Threat to CSL? Thread redpencil 79 85K 0 14/12/23
14/12/23 Charts Thread Comments Created with Sketch. 79 Views Created with Sketch. 85K Likes Created with Sketch. 0
Charts CSL Re: Is Aegros a genuine Threat to CSL? Thread Lucretious 79 85K 1 14/12/23
14/12/23 Charts Thread Comments Created with Sketch. 79 Views Created with Sketch. 85K Likes Created with Sketch. 1
refresh Created with Sketch. REFRESH

Featured News

NEWS Watch Exclusive Interviews with ASX Leaders
right-arrow Created with Sketch.
NEWS Agreement to acquire 50% of the Central Tanami Gold Project
right-arrow Created with Sketch.
NEWS Anson Progresses POSCO Due Diligence with Bulk Green River Brine Shipment to Korea
right-arrow Created with Sketch.
NEWS Thick zone of high-grade gold mineralisation intersected at Fairview South
right-arrow Created with Sketch.
NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Mandalay Resources Discovers High-Grade Skarn and Provides Update on Near Mine Exploration at Björkdal
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$248.39 		Change
0.940(0.38%) 		Mkt cap ! $120.2B
Open High Low Value Volume
$247.65 $249.87 $245.75 $183.3M 738.0K

Buyers (Bids)

No. Vol. Price($)
1 100 $248.01
 

Sellers (Offers)

Price($) Vol. No.
$248.39 251 1
View Market Depth
Last trade - 16.12pm 17/07/2025 (20 minute delay) ?
CSL (ASX) Chart

Top Stories

ASX Market Open: Can we squeeze one more record reset into Week 29? | July 18

The Australian sharemarket is set to follow a record-setting Wall Street higher today, with a green end to the week @ ASX 200 futures are up +0.4% @ seemingly inevitable on U.S. headwinds and rising unemployment rates.Listen to the HotCopper podcast for in-depth discussions and insights on all th...
Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist Welcome to this week’s HotCopperWire, our market watch podcast! Each week, HotCopper’s senior markets reporter Jonathon Davidson and I take you through the week’s biggest news headlines @ and what they mean for Oz investors.In this Week 29 epis...
Great Divide 'rapidly evolving' into commercial miner with first Challenger pour Great Divide Mining (ASX:GDM) has poured first gold at its Challenger gold mine in New South Wales, a crucial step as the ASX-listed mining company @rapidly evolves” into a commercial business with guaranteed cash flow.Listen to the HotCopper podcast for in-depth discussions...
Unemployment expectations correctly called today's 4.3% rate While the jump in unemployment to 4.3% revealed by today's Australian Bureau of Statistics data caught some by surprise, there...
ASX Market Close: Pretty boring day, but we're back in the 8,600s Good Afternoon and welcome to HotCopper’s Market Close for Thursday, I’m Jon Davidson. It was a bit of a nothing day...

Featured News

NEWS Nyrada advances to final cohort in Phase I clinical trial of Xolatryp
right-arrow Created with Sketch.
NEWS Agreement to acquire 50% of the Central Tanami Gold Project
right-arrow Created with Sketch.
NEWS Thick zone of high-grade gold mineralisation intersected at Fairview South
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist
right-arrow Created with Sketch.
NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.